Overexpressed VLA-4 on endothelial cell membrane camouflaging the pathological reactive oxygen species responsive prodrug to enhance target therapy for atherosclerosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpressed VLA-4 on endothelial cell membrane camouflaging the pathological reactive oxygen species responsive prodrug to enhance target therapy for atherosclerosis
Authors
Keywords
-
Journal
CHEMICAL ENGINEERING JOURNAL
Volume 442, Issue -, Pages 136198
Publisher
Elsevier BV
Online
2022-04-06
DOI
10.1016/j.cej.2022.136198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bio-inspired nanomaterials as novel options for the treatment of cardiovascular disease
- (2021) Rajendran JC Bose et al. DRUG DISCOVERY TODAY
- “Plug and Play” Functionalized Erythrocyte Nanoplatform for Target Atherosclerosis Management
- (2021) Yuan Zhong et al. ACS Applied Materials & Interfaces
- VCAM-1 as a predictor biomarker in cardiovascular disease
- (2021) Mayarling Francisca Troncoso et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The Exosomes: Staring biomarkers and novel therapeutic strategies
- (2021) Farzad Koosha et al. CURRENT PHARMACEUTICAL DESIGN
- Implications for the role of lipopolysaccharide in the development of atherosclerosis
- (2021) Armita Mahdavi Gorabi et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs
- (2021) Joon Ho Park et al. Science Advances
- Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy
- (2020) Hong-Ying Chen et al. Acta Biomaterialia
- Corrigendum to “Stem Cell Membrane-Coated Au-Ag-PDA Nanoparticle-Guided Photothermal T Acne Therapy”, Colloids and Surfaces B: Biointerfaces (2020) 192C/COLSUB_111145]
- (2020) Tianqi Meng et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
- (2020) Lang Rao et al. ADVANCED MATERIALS
- Cancer Cell Membrane Camouflaged Semi‐Yolk@Spiky‐Shell Nanomotor for Enhanced Cell Adhesion and Synergistic Therapy
- (2020) Mengyun Zhou et al. Small
- ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule
- (2020) Di Liu et al. Science Advances
- lncRNA NEAT1 ameliorates LPS‑induced inflammation in MG63 cells by activating autophagy and suppressing the NLRP3 inflammasome
- (2020) Wenyu Dai et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy
- (2020) Ping Gong et al. Cancers
- Statin Toxicity
- (2019) Natalie C. Ward et al. CIRCULATION RESEARCH
- Talin-Dependent Integrin Activation Regulates VE-Cadherin Localization and Endothelial Cell Barrier Function
- (2019) Fadi E. Pulous et al. CIRCULATION RESEARCH
- Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy
- (2019) Bingjun Sun et al. Acta Biomaterialia
- Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy
- (2019) Peng Lv et al. NANO LETTERS
- Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management
- (2019) Yi Wang et al. Advanced Science
- Antioxidants and Atherosclerosis: Mechanistic Aspects
- (2019) Khojasteh Malekmohammad et al. Biomolecules
- Cyclodextrin‐Derived Intrinsically Bioactive Nanoparticles for Treatment of Acute and Chronic Inflammatory Diseases
- (2019) Jiawei Guo et al. ADVANCED MATERIALS
- Punicalagin Prevents Inflammation in LPS-Induced RAW264.7 Macrophages by Inhibiting FoxO3a/Autophagy Signaling Pathway
- (2019) Cao et al. Nutrients
- Cancer Cell Membrane Vesicle for Multiplex MicroRNA Imaging in Living Cells
- (2019) Huiting Lu et al. ANALYTICAL CHEMISTRY
- A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases
- (2019) Runjun Zhang et al. BIOMATERIALS
- Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis
- (2018) Xianxian Wu et al. Cell Death & Disease
- Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis
- (2018) Qiangzhe Zhang et al. Nature Nanotechnology
- Epidemiology of cardiovascular disease in China: current features and implications
- (2018) Dong Zhao et al. Nature Reviews Cardiology
- Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome
- (2017) Junnan Tang et al. Nature Communications
- Cancer Cell Membrane–Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy
- (2016) Ze Chen et al. ACS Nano
- Cardiovascular disease in Europe: epidemiological update 2016
- (2016) Nick Townsend et al. EUROPEAN HEART JOURNAL
- Nanoparticle biointerfacing by platelet membrane cloaking
- (2015) Che-Ming J. Hu et al. NATURE
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Oxalyl Chloride as a Practical Carbon Monoxide Source for Carbonylation Reactions
- (2015) Steffen V. F. Hansen et al. ORGANIC LETTERS
- Endothelial destabilization by angiopoietin-2 via integrin β1 activation
- (2015) Laura Hakanpaa et al. Nature Communications
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
- (2014) Ronnie H. Fang et al. NANO LETTERS
- Actin polymerization stabilizes α4β1 integrin anchors that mediate monocyte adhesion
- (2012) Jacob Rullo et al. JOURNAL OF CELL BIOLOGY
- 18F-4V for PET–CT Imaging of VCAM-1 Expression in Atherosclerosis
- (2009) Matthias Nahrendorf et al. JACC-Cardiovascular Imaging
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started